The First European Commission’s Artificial Intelligence Act

By Staff Writer

December 12, 2023

Artificial Intelligence Act European Commission

The European Commission has recently announced a ground-breaking political agreement on the Artificial Intelligence Act (AI Act), marking a historic moment in the field of AI. The AI Act, proposed in April 2021, is the first-ever comprehensive legal framework on Artificial Intelligence worldwide and is set to transpose European values to a new era. The Commission’s President, Ursula von der Leyen, highlighted that AI is already transforming our everyday lives and promises enormous benefits to our economy and society.

The European Approach to Trustworthy AI

The new rules will be applied uniformly across all Member States, following a futureproof definition of AI. The Act adopts a risk-based approach, categorising AI systems into minimal risk, high risk, and unacceptable risk. Minimal risk applications such as AI-enabled recommender systems or spam filters will be free from obligations. High-risk AI systems, including certain critical infrastructures, medical devices, and certain systems used in law enforcement, will have to comply with stringent requirements. AI systems considered a clear threat to people’s fundamental rights will be banned.

The Fines for Non-Adherence

The AI Act has laid out stringent penalties for non-compliance. Companies found violating the rules will be subject to fines. The fines range from €35 million or 7% of global annual turnover (whichever is higher) for violations of banned AI applications, €15 million or 3% for violations of other obligations, and €7.5 million or 1.5% for supplying incorrect information. Small and new businesses will be able to get minor fines that are more fair if they break the AI Act. These fines show the importance of the Act and how vital it is to follow them.

The AI Act and AI for General Purpose

The AI Act establishes explicit regulations for general-purpose AI models, enhancing transparency across the entire value chain. Models that present systemic risks will carry extra legal responsibilities. These include risk management, monitoring significant events, model evaluation, and comparative testing. The Commission, businesses, academia, civil society, and other stakeholders will collaboratively develop these responsibilities into actionable conduct rules. This approach to governing general-purpose AI models demonstrates the Act’s extensive reach. Moreover, it aims to foster the responsible development of AI. 

A first for the world, the new European AI office

The European Commission is launching a new, globally unique European AI Office. This office will enforce new rules at both national and European levels. It will collaborate with national market surveillance officials to ensure correct implementation of the Act. A group of independent science experts will play a crucial role for general purpose models. They will alert about systemic risks and assist in classifying and testing the models. Together with national market surveillance authorities, this new office aims to establish a global standard for AI rules. 

Reference url

Recent Posts

comprehensive medication management
      

Cost Savings and Impact of Comprehensive Medication Management in Healthcare

💡 Did you know that comprehensive medication management (CMM) can provide a staggering ROI of up to 12:1 in healthcare?

In our latest article, we explore how effective CMM not only optimizes medication use but also leads to significant cost savings by reducing hospital readmissions and improving patient health outcomes. Discover the transformative impact of these programs on healthcare economics!

Read the full article to learn more about the future of medication management and its economic benefits.

#SyenzaNews #HealthcareInnovation #HealthEconomics #CostEffectiveness

AI Moral Decision-Making
     

AI Moral Decision-Making: Navigating the Complexities of Kidney Allocation Decisions

🌟 Can AI truly grasp the complexities of human moral decision-making?

Our latest update looks into the intricate world of kidney allocation decisions, revealing how AI models can both assist and fall short in mirroring human moral values. 🚀 The findings illuminate the variability in moral considerations and the subjective nature of decision-making, underscoring the need for more sophisticated AI approaches.

Curious about the balance between technology and ethics in healthcare? Uncover the insights in our full article!

#SyenzaNews #AIinHealthcare #HealthcareInnovation #artificialintelligence

AI kidney disease detection
    

AI Kidney Disease Detection: Transforming Eye Screenings for Diabetic Patients

🔍 Did you know that analyzing eye images can predict kidney disease in people with type 2 diabetes?

Researchers from the Universities of Dundee and Glasgow have developed an innovative AI tool that not only detects existing kidney disease with impressive accuracy but also predicts future cases—transforming routine eye screenings into lifesaving insights. This could pave the way for earlier interventions and improved health outcomes.

Curious to learn how this technology could reshape healthcare? Dive deeper into this groundbreaking research [here](https://www.dundee.ac.uk/stories/ai-analysis-eye-images-offers-window-kidney-health-type-2-diabetes).

#SyenzaNews #AIinHealthcare #HealthTech #Innovation

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.